Article

Tau-Clinical Mismatch Identifies Individuals with Co-Pathology and Predicts Clinical Trajectory

2025-07-25

Abstract excerpt

<h4>Importance</h4> The heterogeneous course of Alzheimer’s disease makes it difficult to predict individuals’ cognitive trajectories, which is particularly important in the era of disease modifying therapy. Identifying individuals more likely to have co-pathology and differing disease courses using clinically practical tools remains a critical gap. <h4>Objective</h4> To evaluate tau-clinical mismatch for identi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0ae6f6a3-fe11-5e3c-84cc-18cbde62b4de
DOI: 10.1101/2025.07.25.25332195

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tau-Clinical Mismatch Identifies Individuals with Co-Pathology and Predicts Clinical TrajectoryDOI 10.1101/2025.07.25.25332195Read

Medial temporal lobe Tau-Neurodegeneration <i>mismatch</i> from MRI and plasma biomarkers identifies vulnerable and resilient phenotypes with ADSemantic proximity Read

Neuronal Distribution of Tau Pathology, Microglial Gene Expression Trajectories, and Resilience to Alzheimer diseaseSemantic proximity Read

Machine Learning-Based Multiclass Classification of Cognitive Stages Using Plasma Biomarkers, Clinical Assessments, and Genetic Features: A Repeated Nested Cross-Validation Study in ADNI with External Validation in CNTNSemantic proximity Read

Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer’s DiseaseSemantic proximity Read

Computational Risk Stratification of Preclinical Alzheimer’s in Younger AdultsSemantic proximity Read

Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease.Semantic proximity Read

Alzheimer’s Disease-Like Brain Pattern Biomarker: Capturing Risks and Predicting Disease OnsetSemantic proximity Read

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read

A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer’s diseaseSemantic proximity Read

Alzheimer's disease-like brain pattern biomarker: capturing risks and predicting disease onset.Semantic proximity Read

Multivariate blood biomarkers capture resilience and resistance phenotypes across the Alzheimer’s disease spectrumSemantic proximity Read

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease Semantic proximity Read